Copanlisib - Bayer HealthCare Pharmaceuticals
At a glance
- Drug Originator Bayer Schering Pharma; Memorial Sloan-Kettering Cancer Center; National Cancer Institute (USA)
- Drug Class 3-ring heterocyclic compounds; Amides; Antineoplastics; Imidazoles; Morpholines; Pyrimidines; Quinazolines; Small molecules
- Mechanism of Action Phosphatidylinositol 3 kinase alpha inhibitors; Phosphatidylinositol 3 kinase delta inhibitors
- USA Patent Applicants BAYER HEALTHCARE
- USA Patents 6
- NDAs 1
- International Patents 104
- Patent Applications 535
Disclaimer